Hologic Inc. (HOLX)

[surf1944]

8:05AM Hologic: Breast Brachytherapy Registry Trial Final Results; MammoSite APBI Demonstrates 'Excellent' Cosmesis and Low Local Recurrence (HOLX) 20.84 : Co announces that the final analysis of the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial data confirms previously noted "excellent" results and compares favorably with other forms of accelerated partial breast irradiation and with outcomes seen in patients treated with whole breast irradiation with similar follow-up. "With over 1,400 patients treated and follow-up exceeding five years, it is the only brachytherapy study with over 1,000 patients accrued and five year follow-up available at this time. The final analysis of this trial not only confirmed the efficacy of brachytherapy based partial breast irradiation, but demonstrated that rates of toxicity following treatment remain low and favorable, in line with previously reported toxicity rates using whole breast irradiation."